Background Using reverse genetics we generated a recombinant low-pathogenic LaSota strain

Background Using reverse genetics we generated a recombinant low-pathogenic LaSota strain Newcastle disease virus (NDV) expressing the glycoprotein (GP) of Ebola virus (EBOV) designated rLa-EBOVGP and evaluated its biological characteristic in vivo and in vitro. trypsin. rLa-EBOVGP is usually more resistant to NDV antiserum than the vector NDV and is moderately sensitive to EBOV GP… Continue reading Background Using reverse genetics we generated a recombinant low-pathogenic LaSota strain